Bioplatforms Australia

Apply for access vouchers - Therapeutic Innovation Australia TIA facilities are directly accessible and in most cases can provide subsidised access to capabilities. The Pipeline Accelerator scheme was introduced to further reduce the cost of access to a specifi...

🚀 The Pipeline Accelerator voucher scheme Round 2 is now open!

Vouchers help researchers & SMEs access advanced facilities, from molecular discovery to clinical trials.

🗓 Closes 17 April 2026, 5 pm AEST
👉 therapeuticinnovation.com.au/pipeline-acc...

GBIF and the Bioplatforms Australian Microbiome Initiative are taking the Aussie microbiome to macro scales 🚀🌏

93M occurrence records from 14,000+ samples across 8 datasets have been mobilised via the Australian Microbiome.🦠

👉Explore datasets: www.gbif.org/dataset/sear...

The request for partnership of the Threatened Species Initiative closes this Friday 27 February 2026. Make sure you submit your proposals before the deadline. We are looking forward to further supporting Australian Threatened Species through genomics!🦋🦘🦞🐟🦄🦇🦜🌿🧬

🐄🧬 The Bioplatforms Animal Disease Genomics Initiative is now an official project supporting DAFF Animalplan 2022–2027, Australia’s first national action plan for production animal health. 🦠🔬 #NCRISimpact
👉 Read more: www.agriculture.gov.au/agriculture-...

The 2026 Request for Partnership for the Threatened Species initiative is now open! TSI seeks to
create a foundation of genomic data to advance our understanding of key threatened species in
Australia (fauna and flora), the RFP-2026 closes 27 February.
bioplatforms.com/news/threate...

AVID Initiative supports 17 research groups to generate molecular data for 38 venomous species - Bioplatforms Australia Australia is home to one of the world’s most diverse arrays of venomous species, yet the vast majority remain poorly characterised at the molecular level. The Australian Venom Innovation and Discovery...

The AVID Initiative is supporting 17 research groups to generate molecular data for 38 venomous species across Australia.🐍🧬
These collaborative projects will advance understanding of venom biology, evolution, conservation and biosecurity. bioplatforms.com/avid-initiat...

We’re hiring 4 roles at UWA's Plant Synbio Innovation Centre: Facility Manager + 3 Postdocs (single-cell genomics/screening; molecular tools; construct prototyping). Apply by Jan 20 bit.ly/4qfoftG bit.ly/3MFgD59 bit.ly/4pFT6jf bit.ly/48VkgLw

🧬🌿dartRverse: harnessing the power of R for conservation genomics🔬🧬

Join the dartRverse Conservation Genomics Workshop 8–14 March 2026 at ANU Kioloa or online. Learn hands-on skills in population genetics using R and the dartR ecosystem.

👉More details: cba.anu.edu.au/news-events/...

OzMedicago to deliver national genotype-to-phenotype platform for climate-smart pasture legumes - Bioplatforms Australia A new national research effort, OzMedicago, has begun work to build Australia’s first integrated genotype-to-phenotype resource for annual Medicago species. These nitrogen-fixing pasture legumes under...

🌿OzMedicago will deliver Australia’s first genotype-to-phenotype platform for climate-smart Medicago pasture legumes. The goal is to drive low-emissions, resilient pastures and boost national R&D capacity. #NCRISimpact
👉Read more: bioplatforms.com/ozmedicago-t...

🌊 Senior Research Fellow opportunity at UWA’s OceanOmics Centre 🌊
Join a leading marine genomics program working with eDNA, whole genomes and advanced sequencing.
📍 UWA Crawley | 3-year role
🔗 Apply: external.jobs.uwa.edu.au/cw/en/job/52...

Annual Report 2025 - Bioplatforms Australia Bioplatforms Australia, enabled by NCRIS investment in research infrastructure, is committed to supporting the Australian life sciences community through a diverse access program, provision of targete...

🌟 Our 2025 Annual Report is now available 🌟
Enabled by NCRIS, Bioplatforms Australia continues to support the life sciences community through national research infrastructure and integrated capabilities. #NCRISimpact

Read the report: bioplatforms.com/annual-repor...

The Australian Venom Innovation and Discovery Initiative - Request for Partnership 2025 now open - Bioplatforms Australia Request for Partnership 2025 The Australian Venom Innovation and Discovery (AVID) Initiative is pleased to announce that the 2025 Request for Partnership is now open! Initiative background Australia i...

⏰ Reminder: Applications for the AVID Initiative 2025 close 5pm AEDT, 19 Nov! 🐍🕷️🦂

Join a national effort to unlock the genomics, transcriptomics & proteomics of Australia’s venomous species and drive discovery across health, ag & biotech.

🔗 Apply now: bioplatforms.com/the-australi...

NCRIS vouchers enable new synthetic biology projects across Australia - Bioplatforms Australia Australia’s synthetic biology research community is receiving a significant boost, with a new wave of collaborative projects supported through the NCRIS Synthetic Biology Voucher Scheme, delivered by ...

🚀 Australia’s synthetic biology capability is growing!
New collaborative projects are underway through the Bioplatforms Synthetic Biology Voucher Scheme, connecting researchers & startups with world-class infrastructure.
Read more 👉 bioplatforms.com/ncris-vouche...

Genomic research targets harmful algal blooms in South Australia - Bioplatforms Australia Researchers from Flinders University and the South Australian Genomics Centre (SAGC) are undertaking a whole-genome sequencing project to study Karenia mikimotoi, the microscopic algae suspected to be...

Genomic research is helping tackle harmful algal blooms in South Australia. 🌊🔬 Flinders University and the SA Genomics Centre are sequencing Karenia mikimotoi to uncover the genes behind its toxicity and bloom dynamics.
Read more 👉 bioplatforms.com/genomic-rese...

The Australian Venom Innovation and Discovery Initiative - Request for Partnership 2025 now open - Bioplatforms Australia Request for Partnership 2025 The Australian Venom Innovation and Discovery (AVID) Initiative is pleased to announce that the 2025 Request for Partnership is now open! Initiative background Australia i...

The AVID Initiative Request for Partnership 2025 is now open! Apply by 19 Nov 2025 to join a national effort advancing genomic and proteomic research on Australia's venomous species. 🕷️🐍🪸
🔗 Learn more: bioplatforms.com/the-australi...

A national effort to decode venoms for science and innovation - Bioplatforms Australia Australia harbours one of the world’s richest diversities of venomous species, from spiders and snakes to marine organisms and insects. Venoms play critical ecological roles, helping species hunt, def...

📢Launching the Australian Venom Innovation and Discovery (AVID) Initiative! This national program will generate genomic and proteomic data for venomous species to support research, conservation and innovation. Stay tuned! Learn more: bioplatforms.com/australian-v...

👏 Congrats to Proteomics International on achieving ISO 15189 certification. They also unveiled new results showing PromarkerEso can detect all stages of oesophageal cancer with high accuracy, offering a non-invasive alternative to endoscopy. #NCRISimpact
👉Learn more: www.proteomics.com.au

Celebrating the winners of the 2025 Australian Museum Eureka Prizes - Bioplatforms Australia Bioplatforms Australia congratulates all the winners of the 2025 Australian Museum Eureka Prizes, announced on 3 September at the Australian Museum in Sydney. Now in its 35th year, the Eureka Prizes r...

🏆Congrats to the 2025 @austmus Eureka Prize winners!
Proud to see:
🔹Prof Ian Paulsen – Leadership in Science, Director of the Bioplatforms-supported Australian Genome Foundry
🔹dartR team – Excellence in Research Software
Celebrating Australian science!
bioplatforms.com/celebrating-...

Protecting Victorians through drug surveillance and pill testing initiatives - Bioplatforms Australia Illicit drug use poses a growing public health challenge, with increasingly potent and unpredictable substances circulating in the community. In recent years, new synthetic drugs and dangerous drug mi...

🚨 Protecting Victorians from dangerous drugs:
Researchers at the University of Melbourne’s Metabolomics Australia are supporting RAPID drug surveillance & The Loop pill testing to deliver real-time alerts and reduce drug-related harms.
👉Read more: bioplatforms.com/protecting-v...

New clinical trial platform offers breakthrough in brain cancer research - Bioplatforms Australia Australian researchers have achieved the most promising advance in brain cancer treatment in two decades, with a new clinical trial showing that a targeted drug can shrink previously incurable tumours...

🚨 Breakthrough in brain cancer research: a new trial shows a targeted drug can shrink tumours by up to 90%. Using the Brain POP platform and advanced analysis by Metabolomics Australia, the study is published in Nature. #NCRISimpact
👉Read more: bioplatforms.com/new-clinical...

Bearded Dragon genomes crack the code of sex determination - Bioplatforms Australia Scientists have taken a huge leap forward in understanding how sex is determined in reptiles, thanks to complete genome sequences of each genetic sex representative of the Australian central bearded d...

🐉 Bearded dragon genomes have revealed a surprising master switch for sex determination. Two global teams, two new genomes, and a big leap forward in reptile biology. Read more on our website: bioplatforms.com/bearded-drag...

Project Manager, Precision Medicine Job in Sydney NSW - SEEK Lead the co-design and delivery of an Aboriginal-led precision medicine program to improve health outcomes in NSW.

📢 The Kids Research Institute Australia is hiring a Project Manager (NSW)!

🤝 Work closely with ALIGN and Aboriginal communities
🧬 Co-design & implement an Aboriginal-led precision medicine program
📈 Coordinate research and capacity building

🔗 Learn more and apply here: seek.com.au/job/86286785

Bioplatforms Australia, Australian BioCommons and EMBL sign agreement to advance bioinformatics and biological data infrastructure - Bioplatforms Australia Bioplatforms Australia, Australian BioCommons, and the European Molecular Biology Laboratory (EMBL) are deepening their long-standing collaboration in life science research, focusing on biological dat...

🚨 Bioplatforms Australia, @ausbiocommons.bsky.social & @embl.org have signed a new agreement to boost collaboration in bioinformatics, AI, training & data infrastructure. A big step for life science research in Australia & beyond! 🌏🧬
👉 Read more here: bioplatforms.com/bioplatforms...

Expressions of Interest Paid Internship in Indigenous Genomics

🚨Indigenous students, researchers or professionals can now apply for the 2025 SA Internship in Indigenous Genomics.
This paid 12-week program offers lab training, a research project, and insights into Aboriginal health.
📅Apply by 31 July: sahmri.org.au/careers-and-...

NCRIS Synthetic Biology Voucher Scheme - Bioplatforms Australia

🚨 Now open! The NCRIS Synthetic Biology Voucher Scheme offers up to $50K Primary and $25K Secondary matched funding to access world-class SynBio facilities across Australia.

👉Open to researchers, startups & SMEs.
📅Closes 12th of September.

🔗 Info: bioplatforms.com/ncris-synthe...

Launching the Genomics for Forest Resilience Initiative - Bioplatforms Australia REQUEST FOR PARTNERSHIP COMING SOON! Australia’s forests are facing growing pressures—from climate change and invasive pathogens to fire, drought, and habitat fragmentation. These ecosystems are home ...

🌿 Launching the Genomics for Forest Resilience Initiative 🌿
Australia’s forests face threats from climate change, disease & habitat loss. This national effort uses genomics to help restore & protect native species.

🔬📢 Request for Partnership coming soon! bioplatforms.com/launching-th...

Plant SynBio Australia official launch - Bioplatforms Australia Network of synthetic biology facilities to develop plants ready for future challengesA recent $20M investment from the Commonwealth has led to the development of Plant SynBio Australia (PSBA), a netwo...

🌱 Plant SynBio Australia has launched!
Supported by $20M from the Commonwealth, this new network will drive innovation in climate-resilient ag & sustainable biomanufacturing. #NCRISimpact
📸 Read more + event photos: bioplatforms.com/plant-synbio...

Announcement of the successful recipients of the Pipeline Accelerator 2024-25 - Bioplatforms Australia Therapeutic Innovation Australia  (TIA), in partnership with Phenomics Australia, Bioplatforms Australia and ANSTO’s National Deuteration Facility, is thrilled to announce the successful recipients of...

🚀 $1.3M in vouchers awarded to 40 projects through the Pipeline Accelerator 2024–25! Supported through NCRIS, this national effort supports therapeutic innovation in cancer, heart disease, women's health, neurological disorders and more!
🔗 bioplatforms.com/announcement... #NCRISimpact

Bassiana duperreyi genome research featured on G3 journal cover - Bioplatforms Australia Congratulations to Benjamin Hanrahan, Kirat Alreja and colleagues, whose genome research on the alpine three-lined skink (Bassiana duperreyi) has been selected for the cover of the June 2025 issue of ...

Congratulations to Benjamin Hanrahan, Kirat Alreja and team! Their Bassiana duperreyi genome research has been featured on the June cover of G3: Genes | Genomes | Genetics. A major step forward for reptile genomics! #NCRISimpact
🦎 Read more on our website bioplatforms.com/bassiana-dup...

$12 million grant backs global team to create first synthetic plant chromosome - Bioplatforms Australia A world-first effort to build an artificial chromosome entirely from scratch in plants has received morethan $12 million in funding from the UK’s Advanced Research and Invention Agency (ARIA) through ...

🚀A world-first project to create a synthetic plant chromosome has received $12M from the UK’s ARIA!
Bioplatforms is proud to support this global team, led by UWA and Macquarie University researchers, pushing the frontiers of SyntheticBiology🌱🔬 #NCRISimpact
Read more: bioplatforms.com/12-million-g...